Epstein-Barr virus associated diseases: an update (original) (raw)
Association of Epstein-Barr virus with nasopharyngeal carcinoma and current status of development of cancer-derived cell lines
Charles Gullo
Annals of the Academy of Medicine, Singapore, 2008
View PDFchevron_right
In nasopharyngeal carcinoma-bearing patients, tumors and lymphocytes are infected by different epstein-barr virus strains
Adnene Hammami
International Journal of Cancer, 2001
View PDFchevron_right
Direct detection of Epstein-Barr virus in peripheral blood and comparison of Epstein-Barr virus genotypes present in direct specimens and lymphoblastoid cell lines established from nasopharyngeal carcinoma patients and healthy carriers in Hong Kong
Maria Lung
International Journal of Cancer, 1992
View PDFchevron_right
Epstein--Barr Virus Gene Expression in Nasopharyngeal Carcinoma
Pierre Busson
Journal of General Virology, 1988
View PDFchevron_right
Molecular Localization of Epstein-Barr Virus and BCL-2 Expression in Tissues from Patients infected with Nasopharyngeal Tumors
Ameer Hadi
2015
View PDFchevron_right
Detection of Epstein-Barr Virus in Nasopharyngeal Carcinoma by In Situ Hybridization and Polymerase Chain Reaction
Muntaser Ibrahim
The Laryngoscope, 1997
View PDFchevron_right
Detection of Epstein-Barr Virus in Nasopharyngeal Carcinoma in Sudanese by <i>in Situ</i> Hybridization
E. Elamin, Muntaser Ibrahim
Journal of Cancer Therapy, 2014
View PDFchevron_right
Epstein-Barr virus genes and nasopharyngeal cancer
Ayse Ayhan
2006
View PDFchevron_right
Epstein–Barr virus and carcinogenesis: beyond Burkitt's lymphoma
Lawrence Young
Clinical Microbiology and Infection, 2009
View PDFchevron_right
Epstein-Barr virus and cancers of the head and neck
Adi Rachmiel
American Journal of Otolaryngology, 2001
View PDFchevron_right
Epstein-Barr virus – molecular basis for malignant transformation
Gabriela Tsankova
Scripta Scientifica Medica, 2016
View PDFchevron_right
Therapeutic implications of Epstein–Barr virus infection for the treatment of nasopharyngeal carcinoma
Johan Kurnianda, Jaap Middeldorp
Therapeutics and Clinical Risk Management, 2014
View PDFchevron_right
Epstein-Barr virus expression within keratinizing nasopharyngeal carcinoma
Honglin Chen, Jaap Middeldorp
Journal of Medical Virology, 1998
View PDFchevron_right
Evidence of Epstein-Barr Virus Association with Head and Neck Cancers: A Review
soorebettu prabhu
2016
View PDFchevron_right
Epstein-Barr Virus with Transforming and Early Antigen-inducing Ability Originating from Nasopharyngeal Carcinoma: Mapping of the Viral Genome
N. Raab-traub
Journal of General Virology, 1989
View PDFchevron_right
Epstein-Barr Virus and Human Cancer: Hokkaido University, July 4-6, 2001
Bill Sugden
Cancer Science, 2001
View PDFchevron_right
The differentiated form of nasopharyngeal carcinoma contains epstein-barr virus DNA
N. Raab-traub
International Journal of Cancer, 1987
View PDFchevron_right
Epstein-Barr virus DNA and epithelial markers in nasopharyngeal carcinoma
Prof. Dr. Hartmut Lobeck
Medical Microbiology and Immunology, 2003
View PDFchevron_right
Therapeutic implications of Epstein–Barr virus infection for the treatment of nasopharyngeal carcinoma
Jaap Middeldorp
Therapeutics and Clinical Risk Management, 2014
View PDFchevron_right
Association of Epstein-Barr virus with oral cancers
toshiyuki sasagawa
Human pathology, 2002
View PDFchevron_right
Expression of Epstein-Barr virus in mesopharyngeal and hypopharyngeal carcinomas
toshiyuki sasagawa
Human pathology, 1999
View PDFchevron_right
Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells
Gottfried Spangler
The Journal of general virology, 1997
View PDFchevron_right
Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia
Umapati Prasad, Pathmanathan Rajadurai
American Journal Of Pathology
View PDFchevron_right
Updates on Epstein–Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV
Anam Farzand
Medicina
View PDFchevron_right
Variations Among Isolates of Epstein‐Barr Virus*
N. Raab-traub
Annals of the New York Academy of Sciences, 1980
View PDFchevron_right
Role of the Epstein-Barr Virus ZEBRA Protein and HPV in the Carcinogenesis of Nasopharyngeal Carcinoma
Rkia Dardari
Carcinogenesis, Diagnosis, and Molecular Targeted Treatment for Nasopharyngeal Carcinoma, 2012
View PDFchevron_right
769NPC Cell Lines—Charles Gullo et al Association of Epstein-Barr Virus with Nasopharyngeal Carcinoma and Current Status of Development of Cancer-derived Cell Lines
Charles Gullo
2015
View PDFchevron_right
Prevalence of Epstein Barr Virus in biopsy specimens of nasopharyngeal carcinoma from Serbian patients
Maja Cupic
Archives of Biological Sciences, 2014
View PDFchevron_right
Serological responses of patients with nasopharyngeal carcinoma to an N-terminal Epstein-Barr virus DNA polymerase protein expressed in prokaryotic cells
Li-Sheng Chen
Journal of Biomedical Science, 1994
View PDFchevron_right
Establishment of a nasopharyngeal carcinoma cell line capable of undergoing lytic Epstein-Barr virus reactivation
Pierre Busson
Laboratory investigation; a journal of technical methods and pathology, 2018
View PDFchevron_right
Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: Regulation of infection and phenotypic characterization
Eri Seto
International Journal of Cancer, 2010
View PDFchevron_right
Epstein-Barr virus prevalence in oral squamous cell cancer and in potentially malignant oral disorders in an eastern Hungarian population
Krisztina Szarka
European Journal of Oral Sciences, 2009
View PDFchevron_right